“showed a trend”

However, compared to the former, the latter group showed a trend toward lower hBD-2 levels (2152.5 ± 1251.6 vs. 1716.9 ± 1248.6 pg/mL, respectively; p = 0.057; Fig. 1 A).

Glucose concentrations were lower in 2h‐HF‐2nd compared to CON (SNK; P =.023) and showed a trend to be lower compared to HF (SNK; P =.057); 2h‐HF‐1st showed a trend towards lower glucose concentrations compared to CON (SNK; P =.073).

Our cohort exhibited slow latencies, and our younger participants showed a trend of utilizing this compensation by increasing their strength responses compared with control data ( p = 0.057, with a medium effect size).

Although overweight status (BMI >25.0) was not significantly different between the two IBS clusters, IBS1 [m(sd), 25.52 (5.68)] showed a trend ( t (27) = 1,99, p = .057) toward greater BMI compared to HC-like IBS [20.99 (6.51)], Hedge’s effect size g (Cohen’s d corrected for small sample sizes) = .74.

Moreover, patients in the RAMSES-01 cohort showed a trend with respect to improvement of motor function (odds ratio 1.943, p = 0.057).

Neurofeedback runs - region-of-interest analysis Over all sessions, the average activity of the individual region-of-interest within the auditory cortex (percent signal change in comparison to rest condition) was significantly lower than zero for the continuous group ( t -test, p = 0.0046) while the intermittent group only showed a trend towards down-regulation (p = 0.057, see Fig. 4 A).

CRO showed a trend toward worst outcomes (modified Rankin scale 3–6) at 3 months (OR 3.4, 95% CI 0.96–12, p =0.057).

Results showed that rs9320913 correlated with the brain-spinal cord ( β = −0.23, p value = 0.037) and showed a trend towards association with the brain-frontal cortex (BA9) ( β = -0.15, p value = 0.057) (Supplementary Table 1 ).

In pregnancies complicated by a syndromic diagnosis, there was no direct effect of RoR or SES on the rate of TOP, but a lower Chan SES index score was indirectly associated with a lower rate of TOP, mediated by GA at diagnosis ( P = 0.02), and greater RoR showed a trend toward a similar effect ( P = 0.057) (Table 3 ).

GABA-currents recorded in KO UNT-oocytes showed a trend towards a decrease with respect to WT UNT-injected oocytes ( Fig. 6f , WT UNT, 100 ± 3.51%, n = 90; KO UNT, 87.21 ± 5.93%, n = 77, p = 0.057), while EC 50 and n H ( Fig. 6g ) remained similar (WT UNT, EC 50 = 93.74 ± 5.21 μM, n H = 1.16 ± 0.05, n = 13; KO UNT, EC 50 = 97.8 ± 4.30 μM, n H = 1.24 ± 0.06, n = 18).

Close margins showed a trend toward increased risk that did not reach statistical significance (hazard ratio 2.18, 95% CI 0.98–4.86, p = 0.057; 8 events among 38 patients), likely reflecting limited statistical power given the small number of events.

FDG SUV mean uptake at day 3 correlated with tumor growth day 10 (r 2 = 0.45; P = 0.034) and showed a trend towards correlation with day 7 (r 2 = 0.38; P = 0.057).

However, analysis of the published data by Fisher's Exact test ( Benner, 1999 ; Pazdur et al , 1999 ) showed a trend for increased incidence of grade 3 or 4 diarrhoea with UFT plus LV ( P =0.057), based on a safety population of 406 patients for UFT plus LV and 396 for the Mayo Clinic regimen ( Cunningham and James, 2001 ).

Correspondingly, the loss modulus G ′′ showed a trend towards higher values in MEN + AST than in GBM + MET ( G ′′ = 1084 ± 222 Pa vs. 623 ± 92 Pa, p = 0.057).

On the contrary, the mutant G allele carriers ( n = 37) showed a trend of a greater reduction in serum TC (−9.8 ± 2.0% vs . -4.1 ± 1.6%, P = 0.057) and LDL-C (−14.5 ± 3.3% vs . -4.4 ± 2.5%, P = 0.082) in comparison with their wild type counterparts (C/C, n = 42).

Mean pacing threshold showed a trend for higher threshold at 1 year follow up (0.63 ± 0.26 V and 0.72 ± 0.26 V at 0.4 msec respectively, p = 0.057).

Although the seed voxel selection method based on the next local maximum approach yielded a relatively homogeneous distribution, a post-hoc analysis of the spatial distribution of the seed voxels in the three rs1006737 genotype groups showed a trend for differences in seed region localizations along the y-dimension at different rs1006737 genotype (ANOVA, F(2, 90) = 2.96, p = .057), which was significant if tested for a linear association with rs1006737 genotype (GG<GA<AA, r = .24, p = .023).

POLE -mutant ECs showed a trend toward increased expression of CD274 (PD-L1) ( p = 0.057).

The ratio of peak NT to peak MT showed a trend toward a group difference with a P value slightly above the significance level ( P = 0.057, Fig. 3 D ).

In patients with CCI < 26, HC showed a trend toward lower NL ratio ( P = 0.057) and significantly higher proportion of favorable mGPS scores (42.4% vs. 13.3%, p = 0.002) compared to LC.

Hemoglobin level showed a trend to an increase (10%, p = 0.057) in the RT only group and a significant increase in the RT plus losartan group compared to the control group ( Table 2 ).

For anxiety, the RE group showed a trend toward lower odds (OR, 0.55; P = 0.057), but this did not achieve statistical significance.

Interestingly, remibrutinib treatment showed a trend for reduction in PMA/ionomycin-induced Th17 CD4 + frequencies (Fig. 3 c, p = 0.057 and p = 0.072 for 3 and 30 mg/kg dose, respectively.

BRAF mutated implants showed a trend (p = 0,057) of higher overall p16 immunoreactivity though no such relation was observed for p53.

Subsequent univariate ANOVAs revealed that MA-dependent participants exhibited an increase in total object interactions [ F (1,32) = 11.8, p < 0.01], time spent with objects [ F (1,32) = 11.0, p < 0.01], percent perseverative interactions [ F (1,32) = 15.9, p < 0.001], and showed a trend towards elevated object-proximal sector entries [ F (1,32) = 3.8, p = 0.057] compared to the drug-free comparison group as illustrated in Fig. 1 .